{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Fibrinolytic Agents in Peripheral Arterial Ischaemia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive intra-arterial recombinant tissue plasminogen activator (rt-PA), intra-arterial streptokinase, or intravenous rt-PA."
      },
      "Participants": {
        "score": 2,
        "evidence": "687 participants with peripheral arterial occlusion. Participants were recruited from multiple clinical settings. Eligibility criteria included confirmed peripheral arterial occlusion."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive intra-arterial recombinant tissue plasminogen activator (rt-PA), intra-arterial streptokinase, or intravenous rt-PA."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy and safety of fibrinolytic agents."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was vessel patency at 30 days."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This randomised controlled trial included 687 participants."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Vessel patency was significantly greater with intra-arterial rt-PA compared to intra-arterial streptokinase (P < 0.04) and intravenous rt-PA (P < 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Haemorrhagic complications were more frequent with intravenous rt-PA and intra-arterial streptokinase than with intra-arterial rt-PA (P < 0.05)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not reported."
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}